Work

Phase 1 study of induction chemoimmunotherapy (ICI) with cemiplimab in combination with cisplatin and docetaxel (TPI) in locally advanced squaous cell carcinoma of the head and neck (LA SCCHN).

Year: 2026

Type: conference-abstract

Study design: Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.e18085

Authors: Omayra Sanchez, Leslie Anne Worona, Emily Ramos, Vruti Virani, Julia Miller, Marshal R. Posner, Scott Roof, Kunal K. Sindhu, Richard Lorne Bakst, Eric Michael Genden, Krzysztof Misiukiewicz

Institutions: Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, Mount Sinai Health System, Tampa General Hospital

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162646470

Cites:

Cited by:

Related to: 10